window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 3, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Global health,Partnerships & Funding,Precision medicine,Rare Diseases,Research & Development,Technology and platforms

    PacBio brings isoform-level insights to 1000 Genomes Project with HiFi sequencing

    PacBio is contributing long-read transcriptomic data to the 1000 Genomes [...]

    July 25, 2025
  • Biologics & Biosimilars,Drug Development,Oncology,Research & Development

    Why immunotherapy sometimes fails: Study reveals unintended effects of antibody design

    A new study from researchers in Japan has uncovered a [...]

    July 24, 2025
  • Drug Development,Research & Development,Technology and platforms

    Sygnature Discovery upgrades high-throughput chemistry platform following £1 million investment

    Sygnature Discovery has completed a major upgrade of its high-throughput [...]

    July 23, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding,Research & Development

    AI-powered initiative in Louisiana aims to accelerate ALS drug discovery

    A new AI-led collaboration is being launched to advance drug [...]

    July 23, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Real world evidence,Research & Development

    QuantHealth clinical trial simulations deliver $31.4m savings and 90% accuracy

    QuantHealth has simulated more than 350 clinical trials using its [...]

    July 23, 2025
  • Artificial Intelligence,Clinical Development,Pharmacovigilance,Regulatory Affairs,Research & Development

    Pistoia Alliance expands into pharmacovigilance space with launch of two new initiatives

    Collaboration efforts aim to reduce manual burden of adverse event [...]

    July 22, 2025
  • Biologics & Biosimilars,Drug Development,Oncology,Research & Development,Technology and platforms

    PhoreMost unveils breakthrough platform to rationalise molecular glue drug discovery

    High-throughput GlueSEEKER platform expands druggable space by identifying novel induced [...]

    July 22, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Market Access & Commercialization,Oncology,Patient Centricity,Regulatory Affairs,Research & Development

    Neuraxpharm expands global reach with launch of Australian affiliate

    Neuraxpharm Group, a leading European specialty pharmaceutical company focused on [...]

    July 22, 2025
  • CDMOs & Manufacturing,Research & Development,Supply Chain & Logistics,Technology and platforms

    Bayesian calibration framework boosts digital twin accuracy in complex manufacturing environments

    A new calibration approach developed by researchers in South Korea [...]

    July 22, 2025
  • Clinical Trials,Drug Development,Oncology,Precision medicine,Research & Development

    Scancell’s iSCIB1+ shows 69% response rate in advanced melanoma in Phase 2 study

    Scancell has reported updated results from its Phase 2 SCOPE [...]

    July 22, 2025
Previous252627Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Evotec unit secures BARDA deal to optimise Ebola antibody manufacturing
    Categories: Biomanufacturing, CDMOs & Manufacturing, Infectious Diseases, Partnerships & Funding, Vaccines
  • Mestag Therapeutics raises $40M and adds leadership ahead of cancer trial
    Categories: Biotech, CDMOs & Manufacturing, Clinical Trials, Funding, Healthcare leadership, Oncology
  • PolyPid prepares D-PLEX100 NDA following Phase 3 surgical infection data
    Categories: Clinical Development, Clinical Trials, Drug Development, FDA, Infectious Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top